A survey of compliance with stereotactic ablative body radiotherapy quality recommendations
Details
Publication Year 2023-06,Volume 67,Issue #4,Page 435-443
Journal Title
Journal of Medical Imaging and Radiation Oncology
Publication Type
Research article
Abstract
INTRODUCTION: Many publications have proposed quality standards for stereotactic ablative body radiotherapy (SABR). However, data on the level of compliance with these guidelines is lacking in the literature. This study aimed to understand how these guidelines are applied in the clinic and to identify barriers to implementing such recommendations. METHODS: Interviews were conducted with multidisciplinary staff at radiation oncology centres across New South Wales formulated around the RANZCR Guidelines for Safe Practice of Stereotactic Body (Ablative) Radiation Therapy. The interview responses were grouped into 20 topics, assessed against the guidelines and thematically analysed. RESULTS: Good compliance with the guidelines was found, with more than 80% of centres achieving satisfactory results in more than half the topics. The areas with the lowest compliance were auditing, risk assessment and reporting recommendations. Barriers to the quality of SABR treatments included limited training opportunities, low patient numbers and a lack of clear requirements on comprehensive auditing and reporting. CONCLUSION: Overall, the centres surveyed reported good compliance with most of the RANZCR SABR guidelines. The tasks with the lowest compliance were those that monitor quality outcomes. Potential strategies for improvement include inclusion in clinical trials and the use of databases which link treatment parameters, dosimetry and outcomes. Further work will focus on the barriers identified in this survey and propose practical solutions to improve compliance in these areas.
Publisher
Wiley
Keywords
Humans; *Lung Neoplasms/radiotherapy; *Radiosurgery/methods; Surveys and Questionnaires; New South Wales; Sabr; guidelines; radiation oncology; survey
Department(s)
Physical Sciences
PubMed ID
36996443
Open Access at Publisher's Site
https://doi.org/10.1111/1754-9485.13526
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2023-09-05 06:53:44
Last Modified: 2023-09-05 06:54:04

© 2024 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙